Moreover, loss-of-function mutations in ARID1A in breast cancer lead to hyperacetylation of histone H4 and facilitation of BET-induced transcription, also leading to sensitivity to small molecule BET inhibitors (BETi) (16). The gene discussed is DNER; the disease is breast carcinoma.